Detailed Information on Publication Record
2021
Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
VESELY, O., P. MARSIK, V. JAROSOVA, I. DOSKOCIL, Karel ŠMEJKAL et. al.Basic information
Original name
Metabolism of Selected 2-Arylbenzofurans in a Colon In Vitro Model System
Authors
VESELY, O., P. MARSIK (guarantor), V. JAROSOVA, I. DOSKOCIL, Karel ŠMEJKAL (203 Czech Republic, belonging to the institution), P. KLOUCEK and J. HAVLIK
Edition
Foods, BASEL, MDPI, 2021, 2304-8158
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 5.561
RIV identification code
RIV/00216224:14160/21:00124273
Organization unit
Faculty of Pharmacy
UT WoS
000723342700001
Keywords in English
moracin C; mulberrofuran G; mulberrofuran Y; permeability assay; Caco-2 cells; intestinal fermentation; LC-MS-Q-TOF
Tags
International impact, Reviewed
Změněno: 23/2/2022 16:22, JUDr. Sabina Krejčiříková
Abstract
V originále
2-arylbenzofurans represent a small group of bioactive compounds found in the plant family Moraceae. As it has not been investigated whether these substances are stable during passage through the gastrointestinal tract, their biological effects may be altered by the metabolism of intestinal microbiota or cells. The aim of the present study was to investigate and compare mulberrofuran Y (1), moracin C (2), and mulberrofuran G (3) in an in vitro model of human intestinal bacterial fermentation and in an epithelial model using the Caco-2 cell line. The analysis of compounds by LC-MS-Q-TOF showed sufficient stability in the fermentation model, with no bacterial metabolites detected. However, great differences in the quantity of permeation were observed in the permeability assay. Moreover, mulberrofuran Y (1) and moracin C (2) were observed to be transformed into polar metabolites by conjugation. Among the test compounds, mulberrofuran Y (1) was mostly stable and accumulated in endothelial cells (85.3%) compared with mulberrofuran G (3) and moracin C (2) (14% and 8.2%, respectively). Thus, only a small amount of mulberrofuran Y (1) was conjugated. Moracin C (2) and mulberrofuran G (3) were metabolized almost completely, with only traces of the unchanged molecule being found on the apical and cellular sides of the system. Only conjugates of mulberrofuran Y (1) and moracin C (2) were able to reach the basolateral side. Our results provide the basic description of bioavailability of these three compounds, which is a necessary characteristic for final evaluation of bio-efficacy.
Links
MUNI/A/1688/2020, interní kód MU |
|